Neblasca, Louise .

HRN: 17-16-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2024
CEFUROXIME 750MG (VIAL)
12/27/2024
01/03/2025
IVTT
645
Q8h
AGE With Moderate Dehydration
Waiting Final Action 
12/28/2024
CEFUROXIME 750MG (VIAL)
12/28/2024
01/03/2025
IV
465
Q8h
Age With Mod Dhn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: